Atlas Trials

Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD

Clinical trial NCT02704390 · COMPLETED

Trial details

NCT number
NCT02704390
Sponsor
Orient Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Attention Deficit Hyperactivity Disorder
Start date
2016-01-01
Primary completion
2019-08-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.